GLAND PHARMA
Quarterly Results Analysis [Jun2025]
GLAND PHARMA Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,506 Cr | ₹1,425 Cr | ₹1,384 Cr | ₹1,406 Cr | ₹1,402 Cr | ₹1,537 Cr | ₹1,545 Cr | ₹1,373 Cr |
Expenses | ₹1,138 Cr | ₹1,077 Cr | ₹1,024 Cr | ₹1,109 Cr | ₹1,137 Cr | ₹1,179 Cr | ₹1,189 Cr | ₹1,049 Cr |
Operating Income | ₹368 Cr | ₹348 Cr | ₹360 Cr | ₹297 Cr | ₹264 Cr | ₹359 Cr | ₹356 Cr | ₹324 Cr |
Other Income | ₹58 Cr | ₹44 Cr | ₹58 Cr | ₹60 Cr | ₹51 Cr | ₹42 Cr | ₹37 Cr | ₹53 Cr |
Interest | ₹11 Cr | ₹7 Cr | ₹23 Cr | ₹6 Cr | ₹6 Cr | ₹10 Cr | ₹5 Cr | ₹6 Cr |
Depreciation | ₹101 Cr | ₹96 Cr | ₹96 Cr | ₹94 Cr | ₹92 Cr | ₹93 Cr | ₹105 Cr | ₹81 Cr |
Profit Before Tax | ₹313 Cr | ₹288 Cr | ₹299 Cr | ₹257 Cr | ₹218 Cr | ₹298 Cr | ₹283 Cr | ₹290 Cr |
Profit After Tax | ₹215 Cr | ₹187 Cr | ₹205 Cr | ₹164 Cr | ₹144 Cr | ₹192 Cr | ₹192 Cr | ₹194 Cr |
EPS | ₹13.08 | ₹11.32 | ₹12.42 | ₹9.93 | ₹8.73 | ₹11.68 | ₹11.65 | ₹11.78 |
Industry Peers & Returns | 1W | 1M | 1Y |
GLAND PHARMA | 0.2% | -4.4% | 0.3% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | -0.9% | -13% |
DIVIS LABORATORIES | -1.6% | -1.8% | 17.9% |
CIPLA | -1.8% | 3.7% | -6% |
TORRENT PHARMACEUTICALS | 0.7% | 2.4% | 3.4% |
DR REDDYS LABORATORIES | -0.6% | 4.5% | -6.5% |
MANKIND PHARMA | 1.4% | 1% | 5.8% |
ZYDUS LIFESCIENCES | 1.3% | 8.2% | -10.1% |
LUPIN | 3.1% | 5.2% | -14.6% |
GLAND PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.66 % |
Y-o-Y | 7.41 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹1,506 Cr | 5.66 | |
Mar2025 | ₹1,425 Cr | 2.95 | |
Dec2024 | ₹1,384 Cr | -1.55 | |
Sep2024 | ₹1,406 Cr | 0.29 | |
Jun2024 | ₹1,402 Cr | -8.83 | |
Mar2024 | ₹1,537 Cr | -0.50 | |
Dec2023 | ₹1,545 Cr | 12.50 | |
Sep2023 | ₹1,373 Cr | - |
GLAND PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 5.83 % |
Y-o-Y | 39.09 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹368 Cr | 5.83 | |
Mar2025 | ₹348 Cr | -3.46 | |
Dec2024 | ₹360 Cr | 21.17 | |
Sep2024 | ₹297 Cr | 12.35 | |
Jun2024 | ₹264 Cr | -26.28 | |
Mar2024 | ₹359 Cr | 0.63 | |
Dec2023 | ₹356 Cr | 9.97 | |
Sep2023 | ₹324 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.16 % |
Y-o-Y | 29.53 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 24.43% | 0.16 | |
Mar2025 | 24.39% | -6.23 | |
Dec2024 | 26.01% | 23.10 | |
Sep2024 | 21.13% | 12.04 | |
Jun2024 | 18.86% | -19.16 | |
Mar2024 | 23.33% | 1.17 | |
Dec2023 | 23.06% | -2.29 | |
Sep2023 | 23.6% | - |
GLAND PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 15.51 % |
Y-o-Y | 49.89 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹215 Cr | 15.51 | |
Mar2025 | ₹187 Cr | -8.87 | |
Dec2024 | ₹205 Cr | 25.17 | |
Sep2024 | ₹164 Cr | 13.75 | |
Jun2024 | ₹144 Cr | -25.29 | |
Mar2024 | ₹192 Cr | 0.29 | |
Dec2023 | ₹192 Cr | -1.15 | |
Sep2023 | ₹194 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 9.32 % |
Y-o-Y | 39.47 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 14.31 % | 9.32 | |
Mar2025 | 13.09 % | -11.49 | |
Dec2024 | 14.79 % | 27.17 | |
Sep2024 | 11.63 % | 13.35 | |
Jun2024 | 10.26 % | -18.05 | |
Mar2024 | 12.52 % | 0.81 | |
Dec2023 | 12.42 % | -12.10 | |
Sep2023 | 14.13 % | - |
GLAND PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 15.55 % |
Y-o-Y | 49.83 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹13.08 | 15.55 | |
Mar2025 | ₹11.32 | -8.86 | |
Dec2024 | ₹12.42 | 25.08 | |
Sep2024 | ₹9.93 | 13.75 | |
Jun2024 | ₹8.73 | -25.26 | |
Mar2024 | ₹11.68 | 0.26 | |
Dec2023 | ₹11.65 | -1.10 | |
Sep2023 | ₹11.78 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD